About Hetero
Hetero is a company based in Hyderabad (India) founded in 1993. It operates as a B2B2C and Reseller / Distribution. The company has 7,319 employees as of November 20, 2024. Hetero has completed 1 acquisition, including Tarbis Farma. Hetero offers products and services including APIs, Global Generics, Biosimilars, and Custom Pharmaceutical Services. Hetero operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
- Headquarter Hyderabad, India
- Employees 7319 as on 20 Nov, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Hetero Labs Limited
- Jurisdiction Balanagar, Telangana, India
-
Annual Revenue
$1.66 B (USD)14.54as on Mar 31, 2023
-
Net Profit
$148.76 M (USD)22.29as on Mar 31, 2023
-
EBITDA
$267.67 M (USD)28.6as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
7319
as on Nov 20, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Hetero
Hetero offers a comprehensive portfolio of products and services, including APIs, Global Generics, Biosimilars, and Custom Pharmaceutical Services.
Active pharmaceutical ingredients are developed for global markets.
Generic drugs are produced for chronic therapy areas.
Biosimilar products are created for sustainable health equity.
Integrated services are offered across the value chain.
People of Hetero
Unlock access to complete
Funding Insights of Hetero
Detailed funding history for Hetero
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Hetero
Hetero has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Tarbis Farma.
Investment portfolio details for Hetero
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Generic and other drugs are manufactured by Tarbis Farma.
|
Locked | Locked | 0 | Locked |
Complete acquisition details for Hetero
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Hetero
Detailed financials for Hetero
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hetero Comparisons
Peer comparison for Hetero
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Hetero
Hetero operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Developer of drugs for the treatment of multiple disorders
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
Detailed competitors of Hetero
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hetero
Complete news archive for Hetero
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hetero
Hetero was founded in 1993.
Hetero is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Nov 20, 2024, the latest employee count at Hetero is 7,319.
Annual revenue of Hetero is $1.66B as on Mar 31, 2023.
Hetero is established as a prominent pharmaceutical company headquartered in Hyderabad, India. Operations are focused on the development and manufacturing of active pharmaceutical ingredients (APIs), global generics, biosimilars, and custom pharmaceutical services. A strong emphasis is placed on research and development to address unmet medical needs. Products are distributed across over 145 countries, supported by 36 state-of-the-art manufacturing facilities. Efforts are made to ensure affordability and accessibility of life-saving medicines worldwide. Partnerships with multinational companies and global agencies are maintained to enhance healthcare standards. Additionally, a commitment to sustainability and community welfare is integrated into the business practices.
Hetero's top competitors include Merck, Roivant Sciences and AbbVie.
Hetero offers APIs, Global Generics, Biosimilars, and Custom Pharmaceutical Services.
Hetero has made 1 acquisition, including Tarbis Farma.